English
Ezetimibe CAS 163222-33-1 Pite 98.5% ~ 102.0% (HPLC) API High Pite Imaj Prezantasyon
  • Ezetimibe CAS 163222-33-1 Pite 98.5% ~ 102.0% (HPLC) API Pite segondè

Ezetimibe CAS 163222-33-1 Pite 98.5% ~ 102.0% (HPLC) API Pite segondè

Deskripsyon kout:

Non: Ezetimibe

CAS: 163222-33-1

Aparans: poud blan ak blan

Pite: 98.5% ~ 102.0% (HPLC)

Ezetimibe (CAS: 163222-33-1) nan tretman Hypercholesterolemia

API meyè kalite, pwodiksyon komèsyal

Inquiry: alvin@ruifuchem.com


Pwodwi detay

Pwodwi ki gen rapò

Tags pwodwi

Deskripsyon:

Manifakti Pwovizyon pou;Segondè Kalite ak pri konpetitif
Ekipman komèsyal Ezetimibe (CAS: 163222-33-1) Entèmedyè ki gen rapò:
(S)-(+)-4-Phenyl-2-oxazolidinone CAS: 99395-88-7
(R)-(+)-2-Methyl-CBS-oxazaborolidine CAS: 112022-83-0
4-(4-Fluorobenzoyl) butyric asid CAS: 149437-76-3
4-[[(4-Fluorophenyl)imino]methyl]-phenol CAS: 3382-63-6
N-(4-(Benzyloxy)benzyliden)-4-fluoroaniline CAS: 70627-52-0
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one CAS 190595-65- 4
(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone CAS: 189028-93-1
(4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one CAS: 189028-95-3
Ezetimibe CAS: 163222-33-1

Pwopriyete chimik:

Non Chimik (3R,4S)-1-(4-Fluorophenyl)-3-[(S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
Sinonim Ezetimibe
Nimewo CAS 163222-33-1
Nimewo CAT RF-API02
Estati Stock Nan stock, pwodiksyon echèl jiska dè santèn de kilogram
Fòmil molekilè C24H21F2NO3
Pwa molekilè 409.43
Pwen k ap fonn 162.0 ~ 166.0 ℃
Mak Ruifu Chimik

Espesifikasyon:

Atik Espesifikasyon
Aparans Poud blan pou blan
Idantifikasyon Pa IR, HPLC
Pite / Metòd analiz 98.5% ~ 102.0% (HPLC)
Wotasyon espesifik -25.0 ° ~ -30.0 °
Imidite (KF) ≤0.50%
Sann sulfate ≤0.10%
Metal lou ≤0.002%
Enantiomère ≤0.30%
Single Max.Enpurte ≤0.50%
Enpurte total ≤1.0%
Tès Creole Enterprise Standard
Itilizasyon Ezetimibe (CAS: 163222-33-1) API

Pake & Depo:

Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.

Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.

Avantaj:

1

FAQ:

2

Aplikasyon:

Ezetimibe (CAS: 163222-33-1) se yon inibitè transpò kolestewòl ki mare nan NPC1L1, ki fè pati yon klas sibstans ki itilize pou bese nivo kolestewòl nan san an se yon dwòg ki diminye nivo kolestewòl nan plasma.Li aji nan diminye absòpsyon kolestewòl nan ti trip la.Yo ka itilize li pou kont li lè yo pa tolere lòt medikaman pou bese kolestewòl, oswa ansanm ak statin (egzanp, ezetimibe/simvastatin) lè statin poukont yo pa kontwole kolestewòl.Ezetimibe se oralman administre pou kont li oswa kòm yon tablèt konbinezon ak swa simvastatin oswa atorvastatin.Ezetimibe te apwouve an 2002 pa FDA a, anba non komèsyal Zetia.Li apwouve pou itilize nan Inyon Ewopeyen an kòm Ezetrol ak lòt non komès.Li pwodui atravè yon pwosesis chimik milti-etap.

Ekri mesaj ou la a epi voye l ba nou